BSE:500730

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

NOCIL Limited manufactures and sells rubber chemicals in India. More Details


Snowflake Analysis

Flawless balance sheet average dividend payer.


Similar Companies

Share Price & News

How has NOCIL's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 500730's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

6.2%

500730

0.9%

IN Chemicals

0.9%

IN Market


1 Year Return

39.9%

500730

17.6%

IN Chemicals

1.9%

IN Market

Return vs Industry: 500730 exceeded the Indian Chemicals industry which returned 17.6% over the past year.

Return vs Market: 500730 exceeded the Indian Market which returned 1.9% over the past year.


Shareholder returns

500730IndustryMarket
7 Day6.2%0.9%0.9%
30 Day13.2%-1.1%-3.1%
90 Day61.9%15.2%8.8%
1 Year44.9%39.9%20.3%17.6%3.8%1.9%
3 Year7.7%-0.2%42.8%34.7%2.5%-2.4%
5 Year245.7%208.7%131.8%112.6%36.9%26.7%

Price Volatility Vs. Market

How volatile is NOCIL's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is NOCIL undervalued compared to its fair value and its price relative to the market?

21.49x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: 500730 (₹142.3) is trading above our estimate of fair value (₹62.93)

Significantly Below Fair Value: 500730 is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: 500730 is poor value based on its PE Ratio (21.5x) compared to the IN Chemicals industry average (15.6x).

PE vs Market: 500730 is poor value based on its PE Ratio (21.5x) compared to the Indian market (16.1x).


Price to Earnings Growth Ratio

PEG Ratio: 500730 is poor value based on its PEG Ratio (1.5x)


Price to Book Ratio

PB vs Industry: 500730 is overvalued based on its PB Ratio (2x) compared to the IN Chemicals industry average (1.1x).


Next Steps

Future Growth

How is NOCIL forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

14.2%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: 500730's forecast earnings growth (14.2% per year) is above the savings rate (7.2%).

Earnings vs Market: 500730's earnings (14.2% per year) are forecast to grow slower than the Indian market (26.5% per year).

High Growth Earnings: 500730's earnings are forecast to grow, but not significantly.

Revenue vs Market: 500730's revenue (21.7% per year) is forecast to grow faster than the Indian market (11.8% per year).

High Growth Revenue: 500730's revenue (21.7% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if 500730's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has NOCIL performed over the past 5 years?

9.2%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 500730 has high quality earnings.

Growing Profit Margin: 500730's current net profit margins (15.2%) are lower than last year (16.6%).


Past Earnings Growth Analysis

Earnings Trend: 500730's earnings have grown by 9.2% per year over the past 5 years.

Accelerating Growth: 500730's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 500730 had negative earnings growth (-34.2%) over the past year, making it difficult to compare to the Chemicals industry average (-2.1%).


Return on Equity

High ROE: 500730's Return on Equity (9.3%) is considered low.


Next Steps

Financial Health

How is NOCIL's financial position?


Financial Position Analysis

Short Term Liabilities: 500730's short term assets (₹4.3B) exceed its short term liabilities (₹1.4B).

Long Term Liabilities: 500730's short term assets (₹4.3B) exceed its long term liabilities (₹1.2B).


Debt to Equity History and Analysis

Debt Level: 500730 is debt free.

Reducing Debt: 500730 has no debt compared to 5 years ago when its debt to equity ratio was 27.1%.

Debt Coverage: 500730 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 500730 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Next Steps

Dividend

What is NOCIL current dividend yield, its reliability and sustainability?

1.76%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: 500730's dividend (1.76%) is higher than the bottom 25% of dividend payers in the Indian market (0.56%).

High Dividend: 500730's dividend (1.76%) is low compared to the top 25% of dividend payers in the Indian market (2.29%).


Stability and Growth of Payments

Stable Dividend: 500730's dividends per share have been stable in the past 10 years.

Growing Dividend: 500730's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonably low payout ratio (37.8%), 500730's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

11.7yrs

Average board tenure


CEO

Sudhir Deo (65 yo)

3.08yrs

Tenure

₹31,209,000

Compensation

Mr. Sudhir Ramchandra Deo has been Managing Director of NOCIL Limited since August 1, 2017. Mr. Deo served as Deputy Managing Director of NOCIL Limited from August 1, 2015 to August 1, 2017. Mr. Deo served ...


CEO Compensation Analysis

Compensation vs Market: Sudhir's total compensation ($USD423.07K) is about average for companies of similar size in the Indian market ($USD385.77K).

Compensation vs Earnings: Sudhir's compensation has been consistent with company performance over the past year.


Board Members

NamePositionTenureCompensationOwnership
Hrishikesh Mafatlal
Executive Chairman15.17yrs₹38.01m0.00054%
₹ 128.9k
Sudhir Deo
MD & Executive Director3.08yrs₹31.21m0.41%
₹ 97.0m
Dhananjay Mungale
Independent Non Executive Director13.5yrs₹2.65mno data
Debnarayan Bhattacharya
Additional Non Executive-Independent Director1.33yrs₹2.73mno data
N. Sankar
Independent Non Executive Director15.17yrs₹1.98mno data
Rohit Arora
Independent Non Executive Director15.17yrs₹2.13mno data
Vilas Gupte
Non-Executive Director15.17yrs₹2.80m0.00036%
₹ 85.9k
Pradeep Bhide
Independent Non-Executive Director9.92yrs₹2.73mno data
Priyavrata Mafatlal
Non-Executive Director3.33yrs₹2.05m0.0073%
₹ 1.7m
Dharmishta Raval
Non-Executive Independent Director6.17yrs₹2.28mno data

11.7yrs

Average Tenure

66yo

Average Age

Experienced Board: 500730's board of directors are seasoned and experienced ( 11.7 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: 500730 insiders have only sold shares in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

NOCIL Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: NOCIL Limited
  • Ticker: 500730
  • Exchange: BSE
  • Founded: 1961
  • Industry: Commodity Chemicals
  • Sector: Materials
  • Market Cap: ₹23.874b
  • Shares outstanding: 165.68m
  • Website: https://www.nocil.com

Location

  • NOCIL Limited
  • Mafatlal House
  • 3rd Floor
  • Mumbai
  • Maharashtra
  • 400020
  • India

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
500730BSE (Mumbai Stock Exchange)YesEquity SharesININRJan 1996
NOCILNSEI (National Stock Exchange of India)YesEquity SharesININRJan 1996

Biography

NOCIL Limited manufactures and sells rubber chemicals in India. The company offers accelerators, anti-degradants, antioxidants, pre vulcanization inhibitors, and post vulcanization stabilizers. It serves t ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/09/30 12:34
End of Day Share Price2020/09/30 00:00
Earnings2020/06/30
Annual Earnings2020/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.